Identification and characterisation of seven novel SERPINA1 null mutations

S. Ottaviani, T. P. Carroll, I. Ferrarotti, A. M. Fra, G. O'Brien, K. Molloy, L. Corda, N. G. McElvaney, M. Luisetti (Pavia, Brescia, Italy; Dublin, Ireland)

Source: International Congress 2014 – Genes and environment in asthma and COPD
Session: Genes and environment in asthma and COPD
Session type: Oral Presentation
Number: 2932
Disease area: Airway diseases

Congress or journal article abstractSlide presentationE-poster

Abstract

BackgroundAlpha-1 antitrypsin (AAT) is a serine protease inhibitor, encoded by the highly polymorphic SERPINA1 gene. Mutations in this gene can lead to AAT deficiency (AATD) which is associated with a substantially increased risk of lung and liver disease. A group of rare mutations causing AATD, termed Null, are characterised by a complete absence of AAT in the plasma, that confer a particularly high risk of emphysema.ObjectivesHere we reported the novel Null AAT mutations that we discovered during the Italian and Irish targeted detection programs of AATD.MethodsWe performed the determination of AAT serum levels by a rate immune nephelometric method or by immune turbidimetry. The phenotype was determined by isoelectric focusing analysis.DNA was isolated from whole peripheral blood or dried blood spot (DBS) samples using a commercial extraction kit. The new mutations were identified by sequencing all coding exons of the SERPINA1 gene.ResultsWe identified seven previously unidentified SERPINA1 Null mutations. Three are nonsense mutations, the others are frameshift mutations caused by deletion of one or two nucleotides. We also performed familial screening. Analysis of the clinical characteristics revealed the recurrence of lung symptoms and lung diseases in M/Null subjects, over 45 years-old, irrespective of their smoking habit.Conclusions We added seven more mutations to the list of SERPINA1 Null alleles. Moreover, we underlined that the laboratory diagnosis of AATD is not just a matter of degree, because the precise determination of the deficiency and Null alleles carried by an AATD individual may help to evaluate the risk for the lung disease.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ottaviani, T. P. Carroll, I. Ferrarotti, A. M. Fra, G. O'Brien, K. Molloy, L. Corda, N. G. McElvaney, M. Luisetti (Pavia, Brescia, Italy; Dublin, Ireland). Identification and characterisation of seven novel SERPINA1 null mutations. Eur Respir J 2014; 44: Suppl. 58, 2932

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Identification and distribution of rare and new mutations of Alpha-1-antitrypsin in Germany
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014

Identification and analysis of rare and novel mutations of the alpha-1-antitrypsin gene
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009


Re-sequencing of PLAUR in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014

Identification and characterisation of twenty-two novel SERPINA1 pathological mutations
Source: Virtual Congress 2020 – Genetic and environmental influences on development of asthma and COPD
Year: 2020




Novel genetic variants in alpha-1 antitripsin deficiency cases carrying S alleles and discordant genotype and serum levels
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

Re-sequencing of IL33 and IL1RL1 in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014

Investigating tensin1 expression and the presence of SNP identified in GWAS in COPD
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Disease modifier genes in cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=50
Year: 2006

Structural and clinical characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019


Polymorphism in SFTPD gene affects assembly and constitutional serum levels of surfactant protein D in a Lebanese population
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014


Primary ciliary dyskinesia caused by loss-of-function GAS8 mutations due to defects of the nexin-dynein regulatory complex
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016


Genetic interaction between ATP2A2 and ORMDL3, a calcium handling origin of asthma
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014

Analysis of the human SP-A 5‘UTR exon B: Identification of regulatory regions
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Evaluation of gene expression during in vitro ciliogenesis to search for novel candidate genes in primary ciliary dyskinesia
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013


Detection of alpha1-antitrypsin deficiency in a European country without national registry yet
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016

The SNPs (-1654C/T, -1641A/G and -1476A/T) of protein C promoter are associated with susceptibility to pulmonary thromboembolism in a chinese population
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

Molecular characterization of novel PiS-like alleles identified in Spanish patients with Alpha-1 antitrypsin deficiency
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Description of new CFTR gene’s mutations in patients of Russia
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


Genome-wide association study identifies new COPD risk locus, PDE4D, in Korean population
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013


Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis: analysis of 5 members of a family
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007